Indo US Bio-Tech Limited Profit Margin

Indo US Bio-Tech Limited (INDOUS.NS) currently reports a profit margin of 10.17% as of June 2026. That compares with 16.2% in the prior-year period — down 37.2% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore Indo US Bio-Tech Limited's profit margin history and peer comparisons.

Indo US Bio-Tech Limited's profit margin decreased from 16.2% to 10.17% — a 37.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Indo US Bio-Tech Limited's profit margin of 10.17% is lower than the its sector sector average of 13.2%. That is roughly 22.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Indo US Bio-Tech Limited's current 10.17% should be judged against industry norms (sector average: 13.2%) and against INDOUS.NS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 10.17%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Indo US Bio-Tech Limited, and consider following INDOUS.NS for alerts when major investors trade the stock.